NHS England improves offer to Vertex over CF drugsNHS officials in England have made an improved two-year pricing deal to Vertex Pharmaceuticals in a bid to Share XNHS England improves offer to Vertex over CF drugshttps://pharmaphorum.com/news/nhs-england-improves-offer-to-vertex-over-cf-drugs/
Lilly moves Crohn’s drug into phase 3, faces safety setback in JapanEli Lilly has had a mixed few days, posting promising trial results for mid-stage Crohn’s disease drug mirikizumab, Share XLilly moves Crohn’s drug into phase 3, faces safety setback in Japanhttps://pharmaphorum.com/news/lilly-moves-crohns-drug-mirikizumab/
After years of delays, NICE backs Celgene’s Revlimid in first-line MMAfter years of delays caused by wrangling over price, NICE has recommended regular NHS funding for Celgene’s Revlimid Share XAfter years of delays, NICE backs Celgene’s Revlimid in first-line MMhttps://pharmaphorum.com/news/after-years-of-delays-nice-backs-celgenes-revlimid-in-first-line-mm/
Gilead faces lawsuit over HIV drug pricingGilead and other pharma companies stand accused of engaging in a scheme to block cheaper competitors to life-saving Share XGilead faces lawsuit over HIV drug pricinghttps://pharmaphorum.com/news/gilead-faces-lawsuit-over-hiv-drug-pricing/
NHS chief hails SMA drug deal – and was that a swipe at Vertex?Children in England with the rare muscle wasting disease spinal muscular atrophy (SMA) will get access to Biogen’s Share XNHS chief hails SMA drug deal – and was that a swipe at Vertex?https://pharmaphorum.com/news/nhs-chief-hails-sma-drug-deal-and-was-that-a-swipe-at-vertex/
Teva vows to fight price-fixing lawsuitTeva has said it will defend itself against a lawsuit raised by 44 US states that alleges the Share XTeva vows to fight price-fixing lawsuithttps://pharmaphorum.com/news/teva-vows-to-fight-price-fixing-lawsuit/
Gilead to donate HIV drug to US government prophylaxis schemeGilead has announced it will donate its HIV drug Truvada to a US-government led prophylaxis programme to end Share XGilead to donate HIV drug to US government prophylaxis schemehttps://pharmaphorum.com/news/gilead-to-donate-hiv-drug-to-us-government-prophylaxis-scheme/
NICE backs Ocrevus for PPMS in England – but with caveatsPatients with a severe progressive form of multiple sclerosis will get access to the first licensed treatment for Share XNICE backs Ocrevus for PPMS in England – but with caveatshttps://pharmaphorum.com/news/nice-backs-ocrevus-for-ppms-in-england-but-with-caveats/
Ionis’ FCS drug approved in EU, launch due in GermanyIonis Pharmaceuticals’ RNA-targeted drug Waylivra has been conditionally approved in Europe for the devastating ultra-rare disease Familial Chylomicronemia Share XIonis’ FCS drug approved in EU, launch due in Germanyhttps://pharmaphorum.com/news/ionis-fcs-drug-approved-in-eu-launch-due-in-germany/
